Cite

HARVARD Citation

    Xu, J. et al. (2020). Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial. Journal of gastroenterology and hepatology. 35 (8), pp. 1307-1316. [Online]. 
  
Back to record